FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Coffee, Tea Tied to Lower Risk of Head and Neck Cancer

2.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

3.

Investigations may result in novel combination therapies for early-stage lung cancers.

4.

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

5.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot